Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018)
Baxter International (BAX) posted quarterly Non-Current Deferred Tax Liability of $205.0 million for Q4 2018, down 26.79% year-over-year from $280.0 million in Q4 2017, and down 26.79% quarter-over-quarter from $280.0 million in Q4 2017.
Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018) Analysis & Trends
Baxter International (BAX) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $205.0 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Non-Current Deferred Tax Liability fell 26.79% year-over-year to $205.0 million; the TTM figure through Dec 2018 stood at $205.0 million (down 26.79% YoY), while the FY2018 annual figure was $205.0 million, down 26.79% from the prior year.
- Non-Current Deferred Tax Liability fell to $205.0 million in Q4 2018 per BAX's latest filing, from $280.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $280.0 million in Q4 2017 and bottomed at $52.0 million in Q1 2015.
- Historically, Non-Current Deferred Tax Liability has averaged $165.5 million across 5 years, with a median of $181.5 million in 2014.
- Annual changes were most pronounced in 2016 — Non-Current Deferred Tax Liability slumped 52.31% — and 2017, when it jumped 201.08%.
- Baxter International's Non-Current Deferred Tax Liability stood at $168.0 million in 2014, then increased by 16.07% to $195.0 million in 2015, then tumbled by 52.31% to $93.0 million in 2016, then surged by 201.08% to $280.0 million in 2017, then declined by 26.79% to $205.0 million in 2018.
- Business Quant data shows BAX's Non-Current Deferred Tax Liability at $205.0 million in Q4 2018, $280.0 million in Q4 2017, and $93.0 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 205.00 Mn |
| Dec 31, 2018 | 205.00 Mn |
| Dec 31, 2017 | 280.00 Mn |
| Dec 31, 2017 | 280.00 Mn |
| Dec 31, 2016 | 93.00 Mn |
| Dec 31, 2016 | 93.00 Mn |
| Dec 31, 2015 | 195.00 Mn |
| Dec 31, 2015 | 195.00 Mn |
| Mar 31, 2015 | 52.00 Mn |
| Mar 31, 2015 | 52.00 Mn |
| Dec 31, 2014 | 168.00 Mn |
| Dec 31, 2014 | 168.00 Mn |